Search - tctmd.com

Displaying 181 - 200 of 552

Sort: Relevancy | Date

Presentation TCT 2022

Hybrid Nano-Coating DES for BTK Disease

Presenter: Terumitsu Hasebe

September 17, 2022

News Conference News TCT 2022

TRILUMINATE Pivotal Trial: First Data Support Safety, Efficacy of TriClip

Caitlin E. Cox

September 17, 2022

Presentation TCT 2022

Computational Simulation for Valve Frame Design and Fatigue Evaluation

Presenter: Craig Bonsignore

September 17, 2022

Presentation TCT 2022

Impact of Cardiovascular Motion on Device Design and Durability

Presenter: Christopher Cheng

September 17, 2022

Presentation TCT 2022

Conclusion

Presenter: Roxana Mehran

September 17, 2022

Presentation TCT 2022

World’s largest RCT for DM - ABILITY DIABETES GLOBAL: Implication and Importance

Presenter: Marie-Claude Morice

September 17, 2022

Presentation TCT 2022

Diabetes and DES+DCB platform: the perfect match

Presenter: Luca Testa

September 17, 2022

Presentation TCT 2022

The role of imaging in DM patients: case presentations from ABILITY RCT

Presenter: Antonio Mangieri

September 17, 2022

Presentation TCT 2022

The Innovative DES+DCB platform

Presenter: Fazila-Tun-Nesa Malik

September 17, 2022

News Conference News TCT 2022

TEER Linked to Better 1-Year Survival in Shock Patients With Significant MR

Yael L. Maxwell

September 17, 2022

News Conference News TCT 2022

Pascal TEER Device as Good as MitraClip in Head-to-Head CLASP IID

Michael O'Riordan

September 17, 2022

News Conference News TCT 2022

PROTECTED TAVR: No Less Stroke With Embolic Protection, but Some See Hope

Todd Neale

September 17, 2022

Presentation TCT 2022

TCT 29: Platelet Reactivity and Clinical Outcomes After Drug-Eluting Stent Implantation in East Asian Patients with Diabetes: Results From the PTRG-DES Registry

Presenter: KI-HYUN JEON

September 17, 2022

Presentation TCT 2022

Hybrid Interventional Approach (DCB + DES): Clinical Indications, Available Data and Future Perspectives

Presenter: Bruno Scheller

September 17, 2022

Presentation TCT 2022

Stent-Free PCI (DCB Only Approach): Insights and Considerations from the SELUTION de NOVO Randomized Control Study

Presenter: Christian M. Spaulding

September 17, 2022

Presentation TCT 2022

TCT 56: Long-term outcomes after bioresorbable vascular scaffold implantation in patients with de-novo coronary artery disease.

Presenter: Marta Konopko

September 17, 2022

Presentation TCT 2022

Sirolimus DCBs: Technological Trends, Challenges and Advantages

Presenter: Ron Waksman

September 17, 2022

Presentation TCT 2022

Sirolimus Coated DCB in All-Comers EASTBOURNE (MagicTouch DCB)

Presenter: Bernardo Cortese

September 17, 2022

Presentation TCT 2022

TCT 758: Low Contrast Protected PCI Combining DES and DEB for the Treatment of Severely Calcified Left Main and Multivessel Disease in a High-Risk Patient

Presenter: Ottavia Cozzi

September 17, 2022

Presentation TCT 2022

DCB for SVD: Primary Outcomes of a Multi-Center RCT with AGENT DCB

Presenter: Paul Underwood

September 17, 2022

Advertisement

Hybrid Nano-Coating DES for BTK Disease

TRILUMINATE Pivotal Trial: First Data Support Safety, Efficacy of TriClip

Computational Simulation for Valve Frame Design and Fatigue Evaluation

Impact of Cardiovascular Motion on Device Design and Durability

Conclusion

World’s largest RCT for DM - ABILITY DIABETES GLOBAL: Implication and Importance

Diabetes and DES+DCB platform: the perfect match

The role of imaging in DM patients: case presentations from ABILITY RCT

The Innovative DES+DCB platform

TEER Linked to Better 1-Year Survival in Shock Patients With Significant MR

Pascal TEER Device as Good as MitraClip in Head-to-Head CLASP IID

PROTECTED TAVR: No Less Stroke With Embolic Protection, but Some See Hope

TCT 29: Platelet Reactivity and Clinical Outcomes After Drug-Eluting Stent Implantation in East Asian Patients with Diabetes: Results From the PTRG-DES Registry

Hybrid Interventional Approach (DCB + DES): Clinical Indications, Available Data and Future Perspectives

Stent-Free PCI (DCB Only Approach): Insights and Considerations from the SELUTION de NOVO Randomized Control Study

TCT 56: Long-term outcomes after bioresorbable vascular scaffold implantation in patients with de-novo coronary artery disease.

Sirolimus DCBs: Technological Trends, Challenges and Advantages

Sirolimus Coated DCB in All-Comers EASTBOURNE (MagicTouch DCB)

TCT 758: Low Contrast Protected PCI Combining DES and DEB for the Treatment of Severely Calcified Left Main and Multivessel Disease in a High-Risk Patient

DCB for SVD: Primary Outcomes of a Multi-Center RCT with AGENT DCB

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content